IRIS / MapLight: A research study of an investigational medication for adolescents and adults with Autism Spectrum Disorder (CURRENTLY RECRUITING)
Interested in participating
If you or your loved one would like to take the next step toward possible participation or if you have more questions, please contact Lily He at lhe@hollandbloorview.ca or 416-425-6220 ext. 6321.
Recruitment Flyer - click here to learn more (PDF)
Additional information
REB #: 3930; A randomized, double-blind, parallel group, placebo-controlled study to investigate the efficacy, safety, and tolerability of ML-004 in adolescents and adults with autism spectrum disorders (ASD)
